ID
15376
Beschreibung
Study documentation part: Discontinuation of Study medication Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.: NCT02461069.
Stichworte
Versionen (1)
- 28.05.16 28.05.16 -
Hochgeladen am
28. Mai 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Discontinuation of Study medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069
Discontinuation of Study medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
Beschreibung
Primary reason for discontinuation of study medication
Beschreibung
Patient requests discontinuation of Study Medication
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0332153
- UMLS CUI [1,2]
- C0558681
Beschreibung
Investigator determines that continuing it would result in a significant risk for that patient
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0420243
Beschreibung
Patient becomes pregnant
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0549206
Beschreibung
Patient withdraws informed consent
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1707492
Beschreibung
Lymphocyte count is < 500/μl, confirmed by two independent measurements 2 weeks apart
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1845611
Beschreibung
Leukocyte count is < 3,000/μl, confirmed by two independent measurements 2 weeks apart
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0948695
Beschreibung
Suspicion of a PML (progressive multifocal leukoencephalopathy)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0023524
Beschreibung
Adverse event
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0877248
Beschreibung
Serious adverse event
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1519255
Beschreibung
Abnormal laboratory value(s) including liver function tests or abnormal test result(s)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0438215
- UMLS CUI [2]
- C0151766
Beschreibung
Use of prohibited medications
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0138547
Beschreibung
Protocol deviation(s)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1705236
Beschreibung
Unsatisfactory therapeutic effect
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1527144
- UMLS CUI [1,2]
- C0439856
Beschreibung
Patient's condition no longer requires study treatment
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1318598
- UMLS CUI [1,2]
- C0683521
Beschreibung
Administrative problems (e.g. patient's non-compliance)
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0033213
Beschreibung
Other reason
Datentyp
text
Alias
- UMLS CUI [1]
- C3840932
Beschreibung
Signature
Ähnliche Modelle
Discontinuation of Study medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
C0558681 (UMLS CUI [1,2])
C0151766 (UMLS CUI [2])
C0138547 (UMLS CUI [1,2])
C0439856 (UMLS CUI [1,2])
C0683521 (UMLS CUI [1,2])
C0033213 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])